Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

NCT00873249 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00873249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00873249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Daily SMS Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
March 31, 2010
Enrollment
339 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia